drugset / Trial / NCT05261321
Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this Phase I non-therapeutic trial is to examine the neurological effects of cannabis on stress reactivity and inhibition in healthy cannabis users. We expect differences between high ratio CBD:THC cannabis oil, low ratio CBD:THC cannabis oil, and/or placebo on outcome measures.
Timeline
- Start
- 2022-10-15
- Primary completion
- 2026-03
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cannabis oil with a high ratio of CBD to THC | Unknown | 5 mg | Oral |
| Comparator | Cannabis oil with a high ratio of CBD to THC | Unknown | 25 mg | Oral |
| Comparator | Cannabis oil with a high ratio of THC to CBD | Unknown | 0.17 mg | Oral |
| Comparator | Cannabis oil with a high ratio of THC to CBD | Unknown | 5 mg | Oral |
Indications
No indication recorded.